Neutropenia and the development of the systemic inflammatory response syndrome

[1]  L. Elting,et al.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Bhagwanjee,et al.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. , 1997, Critical care medicine.

[3]  S. Chanock,et al.  Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. , 1997, Seminars in oncology.

[4]  B. Bennett,et al.  Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia , 1995, British journal of haematology.

[5]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[6]  R. Finberg,et al.  Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  F. Ognibene,et al.  Adult respiratory distress syndrome in patients with severe neutropenia. , 1986, The New England journal of medicine.

[8]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[9]  H. H. Sirnms,et al.  Polymorphonuclear Leukocyte Dysregulation During the Systemic Inflammatory Response Syndrome , 1994 .